Marshall Wace’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-3,011
| Closed | -$294K | – | 2581 |
|
2022
Q4 | $294K | Sell |
3,011
-10,063
| -77% | -$981K | ﹤0.01% | 1992 |
|
2022
Q3 | $3.37M | Buy |
13,074
+8,897
| +213% | +$2.3M | 0.01% | 1352 |
|
2022
Q2 | $777K | Buy |
+4,177
| New | +$777K | ﹤0.01% | 1983 |
|
2022
Q1 | – | Sell |
-871
| Closed | -$142K | – | 3298 |
|
2021
Q4 | $142K | Sell |
871
-2,588
| -75% | -$422K | ﹤0.01% | 2594 |
|
2021
Q3 | $944K | Buy |
+3,459
| New | +$944K | ﹤0.01% | 1584 |
|
2021
Q1 | – | Sell |
-325
| Closed | -$123K | – | 2502 |
|
2020
Q4 | $123K | Sell |
325
-28
| -8% | -$10.6K | ﹤0.01% | 1649 |
|
2020
Q3 | $133K | Sell |
353
-343
| -49% | -$129K | ﹤0.01% | 1465 |
|
2020
Q2 | $342K | Buy |
+696
| New | +$342K | ﹤0.01% | 1268 |
|
2019
Q2 | – | Sell |
-491
| Closed | -$283K | – | 1790 |
|
2019
Q1 | $283K | Sell |
491
-2,069
| -81% | -$1.19M | ﹤0.01% | 1263 |
|
2018
Q4 | $719K | Buy |
2,560
+2,321
| +971% | +$652K | 0.01% | 999 |
|
2018
Q3 | $115K | Buy |
+239
| New | +$115K | ﹤0.01% | 1094 |
|